8-K/A XBRL

FORM 8-K/A

Company: Marker Therapeutics, Inc.
Filed: March 4, 2025
Period of Report: February 12, 2025
Accession Number: 0001104659-25-020405

View Document ↗ View on SEC.gov ↗